A new Class of painkillers may lower overdose deaths
Opioids offer incredible pain relief by acting on neuronal receptors. Unfortunately, they also have a powerful impact on portions of the brain that control respiration, leading to slower breathing – and in many instances – death.
Now, the FDA is in the process of approving a new class of opioid painkillers that provide the positive pain reducing effects, but without the respiratory depression. The first of these products is called Olinvo and was created by Trevena, a Philadelphia-based company.
Are You Open To Starting Addiction Counseling?
Don't Wait. Call Today To Ask About Our Cutting-Edge Programs.(866) 421-6242
Scientists believe Olinvo will be the first of many pain-relieving “biased agonists”—so called because, in binding a key opioid receptor in the central nervous system, they nudge it into a conformation that promotes a signaling cascade that kills pain over one that suppresses breathing.
However, there are sill questions about the addictive nature of these new compounds. “The $64,000 question is: What about dependence?” says Robert Lefkowitz, a biochemist at Duke University in Durham, North Carolina, who shared the 2012 Nobel Prize in Chemistry for his work on G-protein-coupled receptors.
If you are struggling with addiction, treatment is available. Don’t wait any longer to ask for help.
Are you or a loved one struggling with addiction?
Personalized care is available 24/7 at our state-of-the-art clinic. Our Neuro Rehabilitation approach helps address the root causes of addiction once and for all.
To learn more details about the chemistry behind biased opioids, visit Science Magazine.
Don’t Wait. Call Today To Ask About Our Behavioral Health Programs.
The post Will A New Class of Painkillers Reduce Overdoses? appeared first on Florida House Experience.
This post first appeared on News - Florida House Experience | Comprehensive Ad, please read the originial post: here